Regression of left ventricular hypertrophy in diabetics by a candesartan-based regimen in clinical practice

被引：4

作者：

Barrios, Vivencio

Escobar, Carlos

Calderon, Alberto

Vegazo, Onofre

Fernandez, Raul

Asin, Enrique

机构：

[1] Hosp Ramon & Cajal, Dept Cardiol, E-28034 Madrid, Spain

[2] Primary Hlthcare Ctr Rosa Luxemberg, Madrid, Spain

[3] AstraZeneca Med Dept, Madrid, Spain

[4] Hosp Ramon & Cajal, Dept Cardiol, E-28034 Madrid, Spain

来源：

DIABETES RESEARCH AND CLINICAL PRACTICE | 2007年 / 77卷 / 03期

关键词：

D O I：

10.1016/j.diabres.2007.01.008

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：492 / 493

页数：2

共 13 条

[1] ECHOCARDIOGRAPHIC DETERMINATION OF LEFT-VENTRICULAR MASS IN MAN - ANATOMIC VALIDATION OF METHOD [J].

DEVEREUX, RB ;

REICHEK, N .

CIRCULATION, 1977, 55 (04) :613-618

[2] Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus [J].

Gress, TW ;

Nieto, FJ ;

Shahar, E ;

Wofford, MR ;

Brancati, FL .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (13) :905-912

[3] Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension:: principal results of the hypertension optimal treatment (HOT) randomised trial [J].

Hansson, L ;

Zanchetti, A ;

Carruthers, SG ;

Dahlöf, B ;

Elmfeldt, D ;

Julius, S ;

Ménard, J ;

Rahn, KH ;

Wedel, H ;

Westerling, S .

LANCET, 1998, 351 (9118) :1755-1762

[4] Regression of cardiac hypertrophy in type 2 diabetes with hypertension by candesartan [J].

Iwashima, Yasunori ;

Okada, Mizuho ;

Haneda, Masakazu ;

Yoshida, Takeshi .

DIABETES RESEARCH AND CLINICAL PRACTICE, 2006, 74 (01) :8-14

[5] PROGNOSTIC IMPLICATIONS OF BASE-LINE ELECTROCARDIOGRAPHIC FEATURES AND THEIR SERIAL CHANGES IN SUBJECTS WITH LEFT-VENTRICULAR HYPERTROPHY [J].

LEVY, D ;

SALOMON, M ;

DAGOSTINO, RB ;

BELANGER, AJ ;

KANNEL, WB .

CIRCULATION, 1994, 90 (04) :1786-1793

[6] 2003 European society of hypertension -: European Society of Cardiology guidelines for the management of arterial hypertension [J].

Mancia, G ;

Rosei, EA ;

Cifkova, R ;

DeBacker, G ;

Erdine, S ;

Fagard, R ;

Farsang, C ;

Heagerty, AM ;

Kawecka-Jaszcs, K ;

Kiowski, W ;

Kjeldsen, S ;

Lüscher, T ;

McInnes, G ;

Mallion, JM ;

Brien, EO ;

Poulter, NR ;

Priori, SG ;

Rahn, KH ;

Rodicio, JL ;

Ruilope, LM ;

Safar, M ;

Staessen, JA ;

van Zwieten, P ;

Waeber, B ;

Williams, B ;

Zanchetti, A ;

Zannad, F .

JOURNAL OF HYPERTENSION, 2003, 21 (06) :1011-1053

[7] Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy -: The Losartan Intervention for Endpoint (LIFE) Reduction in Hypertension Study [J].

Okin, PM ;

Devereux, RB ;

Gerdts, E ;

Snapinn, SM ;

Harris, KE ;

Jern, S ;

Kjeldsen, SE ;

Julius, S ;

Edelman, JM ;

Lindholm, LH ;

Dahlöf, B .

CIRCULATION, 2006, 113 (12) :1588-1596

[8] Using single nucleotide polymorphisms as a means to understanding the pathophysiology of asthma [J].

Palmer, LJ ;

Cookson, WOCM .

RESPIRATORY RESEARCH, 2001, 2 (02) :102-112

[9] Application of evidence from randomised controlled trials to general practice [J].

Rosser, WW .

LANCET, 1999, 353 (9153) :661-664

[10] DIABETES-MELLITUS AND ASSOCIATED HYPERTENSION, VASCULAR-DISEASE, AND NEPHROPATHY - AN UPDATE [J].

SOWERS, JR ;

EPSTEIN, M .

HYPERTENSION, 1995, 26 (06) :869-879

← 1 2 →